{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:38:32Z","timestamp":1760056712132,"version":"build-2065373602"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11712-w","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:04:56Z","timestamp":1760015096000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Seroprevalence and molecular detection of human t-cell lymphotropic virus type 1 among multi \u2013transfused patients in Sana\u2019a City, Yemen"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6697-0753","authenticated-orcid":false,"given":"Yasser","family":"Ghaleb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5893-2247","authenticated-orcid":false,"given":"Arwa Mohammed","family":"Othman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2952-3120","authenticated-orcid":false,"given":"Rowa M.","family":"Assayaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"1","key":"11712_CR1","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1186\/s12879-020-05344-5","volume":"20","author":"M Aabdien","year":"2020","unstructured":"Aabdien M, Selim N, Himatt S, et al. Prevalence and trends of transfusion transmissible infections among blood donors in the state of Qatar, 2013\u20132017. BMC Infect Dis. 2020;20(1):617.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"11712_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neurol.2011.12.006","volume":"168","author":"A Gessain","year":"2012","unstructured":"Gessain A, Mahieux R. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects. Rev Neurol. 2012;168(3):257\u201369.","journal-title":"Rev Neurol"},{"key":"11712_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12977-019-0483-0","volume":"16","author":"MP Martinez","year":"2019","unstructured":"Martinez MP, Al-Saleem J, Green PL. Comparative virology of HTLV-1 and HTLV-2. Retrovirology. 2019;16:1\u201312.","journal-title":"Retrovirology"},{"key":"11712_CR4","unstructured":"WHO. Human T-lymphotropic virus type 1, factsheet. Availabe online. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/human-t-lymphotropic-virus-type-1.Accessed 5 April 2024. 2023."},{"issue":"4","key":"11712_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1089\/aid.2016.0191","volume":"33","author":"KR Campos","year":"2017","unstructured":"Campos KR, Gon\u00e7alves MG, Caterino-de-Araujo A. Failures in detecting HTLV-1 and HTLV-2 in patients infected with HIV-1. AIDS Res Hum Retroviruses. 2017;33(4):382\u20135.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"11712_CR6","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s42770-021-00609-w","volume":"52","author":"C de Alcantara Maneschy","year":"2021","unstructured":"de Alcantara Maneschy C, dos Santos Barile KA, de Castro JAA, Palmeira MK, de Castro RBH, de Melo Amaral CE. Epidemiological and molecular profile of blood donors infected with HTLV-1\/2 in the state of Par\u00e1, Northern Brazil. Braz J Microbiol. 2021;52:2001\u20136.","journal-title":"Braz J Microbiol"},{"issue":"4","key":"11712_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/v14040664","volume":"14","author":"MR Hedayati-Moghaddam","year":"2022","unstructured":"Hedayati-Moghaddam MR, Jafarzadeh Esfehani R, El Hajj H, Bazarbachi A. Updates on the epidemiology of the human T-cell leukemia virus type 1 infection in the countries of the Eastern Mediterranean Regional Office of the World Health Organization with special emphasis on the situation in Iran. Viruses. 2022;14(4):664.","journal-title":"Viruses"},{"key":"11712_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-020-05344-5","volume":"20","author":"M Aabdien","year":"2020","unstructured":"Aabdien M, Selim N, Himatt S, et al. Prevalence and trends of transfusion transmissible infections among blood donors in the state of Qatar, 2013\u20132017. BMC Infect Dis. 2020;20:1\u20139.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"11712_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4103\/sccj.sccj_13_20","volume":"4","author":"FH Al-Hababi","year":"2020","unstructured":"Al-Hababi FH, Al-Deailej IM, Al-Sulatan HA, Al-Ghamdi YA, Al-Dossari KM. Human T lymphotropic virus antibodies seroprevalence among healthy blood donors and high risk groups at Riyadh regional laboratory in Riyadh, Saudi Arabia. Saudi Crit Care J. 2020;4(2):73\u20138.","journal-title":"Saudi Crit Care J"},{"issue":"2","key":"11712_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/sjamf.sjamf_15_17","volume":"1","author":"HA Al-Kherbash","year":"2017","unstructured":"Al-Kherbash HA, Al-Awdi A, Hasan NS. Pattern and clinical profile of thalassemia among pediatric patients attending the Yemeni society centers for thalassemia and genetic blood disorders in Yemen. Sci J Al-Azhar Med Fac Girls. 2017;1(2):43\u201356.","journal-title":"Sci J Al-Azhar Med Fac Girls"},{"issue":"6","key":"11712_CR11","first-page":"55","volume":"2","author":"H Al-Nood","year":"2005","unstructured":"Al-Nood H, Al\u2010Ismail S, King L, May AJH. Prevalence of the sickle cell gene in Yemen: a pilot study. Yemeni Health Med Res J. 2005;2(6):55\u201344.","journal-title":"Yemeni Health Med Res J"},{"issue":"(3\u20134)","key":"11712_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/03630260903039594","volume":"33","author":"H Al-Nood","year":"2009","unstructured":"Al-Nood H. Thalassemia trait in outpatient clinics of Sana\u2019a City, Yemen. Hemoglobin J. 2009;33((3\u20134)):242\u20136.","journal-title":"Hemoglobin J"},{"key":"11712_CR13","unstructured":"Saif N. Study Of Sickle Cell Disease And Its Relation To Malaria Between Marginal People In Taiz (Yemen). World J Pharmaceutical Res. 2018; 7 (13). 1\u201315."},{"issue":"1","key":"11712_CR14","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1186\/s12889-024-18207-4","volume":"24","author":"A Ibrahim","year":"2024","unstructured":"Ibrahim A, El Baldi M, Mohammed S, El Rhazi K, Benazzouz B. Cancer statistics in Yemen: incidence and mortality, in 2020. BMC Public Health. 2024;24(1):962.","journal-title":"BMC Public Health"},{"key":"11712_CR15","doi-asserted-by":"publisher","first-page":"iii103","DOI":"10.1093\/annonc\/mdq092","volume":"21","author":"R Peris-Bonet","year":"2010","unstructured":"Peris-Bonet R, Salmer\u00f3n D, Mart\u00ednez-Beneito M, et al. Childhood cancer incidence and survival in Spain. Annals Oncol J. 2010;21:iii103\u201310.","journal-title":"Annals Oncol J"},{"key":"11712_CR16","volume":"6","author":"Y Ghaleb","year":"2021","unstructured":"Ghaleb Y, Alshahari A, Ali M, Al-Amad M, Al-Serouri A. Transfusion transmitted infections: prevalence and associated factors, National blood transfusion and research center, sana\u2019a capital, Yemen. J Hematol Hemother. 2021;6:015.","journal-title":"J Hematol Hemother"},{"issue":"2","key":"11712_CR17","first-page":"001","volume":"11","author":"S Patel","year":"2022","unstructured":"Patel S, Kesarwani V, Soni H, Sah N, Purohit M. Seroprevalence of transfusion transmitted infections among multiple transfused patients in Indian scenario: step for safe transfusion practices. Natl J Lab Med. 2022;11(2):001\u20134.","journal-title":"Natl J Lab Med"},{"issue":"4","key":"11712_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1089\/aid.2021.0230","volume":"39","author":"GC Sampaio","year":"2023","unstructured":"Sampaio GC, Ribeiro JR, de Almeida CN, Boa-Sorte N, Galvao-Castro B, Grassi MF, Nunes S\u00e1 K, Dias CM. Human T cell lymphotropic virus type 1 global prevalence associated with the human development index: systematic review with meta-analysis. AIDS Res Hum Retroviruses. 2023;39(4):145\u201365.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"11712_CR19","first-page":"69","volume":"9","author":"S Mohajeri","year":"2023","unstructured":"Mohajeri S, Khaleghi M, Hassanshahian M, et al. Evaluating the prevalence of human T-cell lymphotropic virus in blood donors and thalassemia and hemophilia patients in Rafsanjan and Jiroft cities of Kerman Province, Iran. J Genetic Resour. 2023;9(1):69\u201374.","journal-title":"J Genetic Resour"},{"issue":"4","key":"11712_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/tme.12133","volume":"24","author":"M Keshvari","year":"2014","unstructured":"Keshvari M, Hajibeigi B, Azarkeivan A, et al. Seroepidemiology of human T-cell lymphotropic virus among Iranian adult thalassemic patients. Transfus Med. 2014;24(4):227\u201332.","journal-title":"Transfus Med"},{"key":"11712_CR21","unstructured":"Gorish BM. Prevalence of human T-lymphotropic virus type 1 (HTLV-1) infection among patients with hematologic disorders-serology and molecular based cross-sectional study in Khartoum, Sudan. MedPress Oncol. 2019;1(1)."},{"issue":"1","key":"11712_CR22","first-page":"10","volume":"24","author":"M Naderi","year":"2022","unstructured":"Naderi M, Narooie-Nejad M, Soleimani G, et al. Frequency of human T-cell leukemia virus type 1 in patients with rare bleeding disorders. J Babol Univ Med Sci. 2022;24(1):10\u20137.","journal-title":"J Babol Univ Med Sci"},{"key":"11712_CR23","unstructured":"Al-Rawi JR, Latief AMA, Abdulkareem S. Screening for HTLV 1 & 2 among Iraqi patients with lymphoma and leukemia. Iraqi J Community Med. 2017;30(4)."},{"issue":"11","key":"11712_CR24","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.3390\/v7112904","volume":"7","author":"MR Hedayati-Moghaddam","year":"2015","unstructured":"Hedayati-Moghaddam MR, Tehranian F, Bayati M. Human T-lymphotropic virus type I (HTLV-1) infection among Iranian blood donors: first case-control study on the risk factors. Viruses J. 2015;7(11):5736\u201345.","journal-title":"Viruses J"},{"issue":"2","key":"11712_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009066","volume":"15","author":"LM Bandeira","year":"2021","unstructured":"Bandeira LM, Puga MA, Weis-Torres SM, et al. Human T-cell leukemia virus type 1 infection among Japanese immigrants and their descendants living in Southeast brazil: a call for preventive and control responses. PLoS Negl Trop Dis. 2021;15(2):e0009066.","journal-title":"PLoS Negl Trop Dis"},{"key":"11712_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4690-11-S1-P54","volume":"11","author":"WM Switzer","year":"2014","unstructured":"Switzer WM, Shankar A, Trimble SR, et al. Human T-cell lymphotropic virus type 1 infection among US thalassemia patients. Retrovirology. 2014;11:1\u20131.","journal-title":"Retrovirology"},{"key":"11712_CR27","unstructured":"Ghadiri K, Hashemian AH, Rezaei M, Payandeh M, Zare ME. Serologic prevalence of human T-lymphotropic virus (HTLV) among major thalassemic patients in Kermanshah 2010. Int J Hematology-Oncology Stem Cell Res. 2011:14\u20137."},{"issue":"2","key":"11712_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ajh.2830200205","volume":"20","author":"JM Jason","year":"1985","unstructured":"Jason JM, McDougal JS, Cabradilla C, Kalyanaraman V, Evatt BL. Human T-cell leukemia virus (HTLV\u2010I) p24 antibody in new York City blood product recipients. Am J Hematol. 1985;20(2):129\u201337.","journal-title":"Am J Hematol"},{"issue":"1","key":"11712_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/0090-1229(87)90165-6","volume":"43","author":"K Sanhadji","year":"1987","unstructured":"Sanhadji K, Gessain A, Chout R, et al. HTLV-I antibody and cell-mediated immunity status in sickle cell anemia. Clin Immunol Immunopathol. 1987;43(1):140\u20134.","journal-title":"Clin Immunol Immunopathol"},{"issue":"6","key":"11712_CR30","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.4269\/ajtmh.23-0118","volume":"109","author":"YE Leys","year":"2023","unstructured":"Leys YE, Cameron J, Frater V, et al. Seroprevalence of human T-cell lymphotropic virus\u20131 in a Jamaican antenatal population and assessment of pooled testing as a cost reduction strategy for implementation of routine antenatal screening. Am J Trop Med Hyg. 2023;109(6):1344.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"11712_CR31","first-page":"4","volume":"4","author":"SH Monavari","year":"2019","unstructured":"Monavari SH, Keyvani H, Fazlalipour M, et al. Detection of human T-cell lymphotropic virus Type-1 among patients with malignant hematological diseases in capital of Iran, Tehran. Adv J Virol Epidemic Pandemic Dis. 2019;4(1):4\u20138.","journal-title":"Adv J Virol Epidemic Pandemic Dis"},{"key":"11712_CR32","doi-asserted-by":"publisher","first-page":"1288990","DOI":"10.3389\/fmicb.2023.1288990","volume":"14","author":"H Ji","year":"2023","unstructured":"Ji H, Chang L, Yan Y, Sun H, Liu Y, Wang L. Genetic typing and intrafamilial transmission of human T-lymphotropic virus type 1 in non-endemic areas of China. Front Microbiol. 2023;14:1288990.","journal-title":"Front Microbiol"},{"key":"11712_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00404-011-2211-4","volume":"286","author":"C van Tienen","year":"2012","unstructured":"van Tienen C, Jakobsen M, van der Schim M. Stopping breastfeeding to prevent vertical transmission of HTLV-1 in resource-poor settings: beneficial or harmful? Archives Gynecol Obstet. 2012;286:255\u20136.","journal-title":"Archives Gynecol Obstet"},{"key":"11712_CR34","doi-asserted-by":"publisher","first-page":"039463202210969","DOI":"10.1177\/03946320221096909","volume":"36","author":"M Riaz","year":"2022","unstructured":"Riaz M, Abbas M, Rasool G, et al. Prevalence of transfusion-transmitted infections in multiple blood transfusion-dependent thalassemic patients in Asia: a systemic review. Int J Immunopathol Pharmacol. 2022;36:03946320221096909.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"11712_CR35","doi-asserted-by":"publisher","DOI":"10.2196\/36557","volume":"8","author":"S Moghalles","year":"2022","unstructured":"Moghalles S, Al Serori A, Shamsan A. Prevalence of and factors associated with transfusion-transmitted infections among multi-transfused patients, Sana\u2019a City, Yemen, 2019. Iproceedings. 2022;8(1):e36557.","journal-title":"Iproceedings"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11712-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11712-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11712-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:05:09Z","timestamp":1760015109000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11712-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11712"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11712-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complies with the ethical principles outlined in the Declaration of Helsinki concerning research involving human subjects. The proposal for this study was approved by the Research Medical Committee at the Faculty of Medicine and Health Sciences at Sana\u2019a University (May 5th,2023: Ref.1184). Permission of the centers and hospital was secured and written consent was taken from patients and Children\u2019s parents. Feedback regarding the results of the study was given to the participants at the end of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1261"}}